IFNG and neoplasm: Notably, tumor-derived PGE2-mediated activation of nuclear p50 NF-κB epigenetically shifts the response of monocytic cells to IFN-γ toward an immunosuppressive phenotype, which enhances the anticancer properties of IFN-γ [75].